aspartic acid has been researched along with Hepatitis B in 6 studies
Aspartic Acid: One of the non-essential amino acids commonly occurring in the L-form. It is found in animals and plants, especially in sugar cane and sugar beets. It may be a neurotransmitter.
aspartic acid : An alpha-amino acid that consists of succinic acid bearing a single alpha-amino substituent
L-aspartic acid : The L-enantiomer of aspartic acid.
Hepatitis B: INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We report a patient whose cryoglobulinemic vasculitis recurred due to reactivation of lamivudine-resistant HBV." | 7.73 | Successful treatment with adefovir of one patient whose cryoglobulinemic vasculitis relapsed under lamivudine therapy and who was diagnosed to have HBV virologic breakthrough with YMDD mutations. ( Cakir, N; Midilli, K; Pamuk, ON; Umit, H, 2006) |
| "To analyse the emergence of YMDD motif (tyrosine-methionine-aspartate-aspartate) variants in patients with hepatitis B treated with lamivudine." | 7.71 | PCR restriction fragment length polymorphism in detection of YMDD variants of viral polymerase in hepatitis B virus patients treated with lamivudine. ( Fan, J; Liang, WF; Xie, YJ; Yang, DH; Zhao, NF, 2002) |
| " Univariate analyses were conducted to determine the association among gender, age, hepatocellular carcinoma, hepatitis B e antigen-positive status, HBV-DNA level and tyrosine-methionine-aspartate-aspartate (YMDD) mutations on HBV recurrence in these patients." | 3.80 | Clinical-pathological analysis of hepatitis B virus recurrence after liver transplantation in Chinese patients. ( Gao, YJ; Jin, B; Li, HW; Liu, ZW; Ma, XM; Meng, FP; Su, HB; Zhang, M; Zhao, JM, 2014) |
| "We report a patient whose cryoglobulinemic vasculitis recurred due to reactivation of lamivudine-resistant HBV." | 3.73 | Successful treatment with adefovir of one patient whose cryoglobulinemic vasculitis relapsed under lamivudine therapy and who was diagnosed to have HBV virologic breakthrough with YMDD mutations. ( Cakir, N; Midilli, K; Pamuk, ON; Umit, H, 2006) |
| "To analyse the emergence of YMDD motif (tyrosine-methionine-aspartate-aspartate) variants in patients with hepatitis B treated with lamivudine." | 3.71 | PCR restriction fragment length polymorphism in detection of YMDD variants of viral polymerase in hepatitis B virus patients treated with lamivudine. ( Fan, J; Liang, WF; Xie, YJ; Yang, DH; Zhao, NF, 2002) |
| "The prevalence of hepatotoxicity, liver fibrosis, and CKD were 7." | 1.51 | Evaluation of hepatic and kidney dysfunction among newly diagnosed HIV patients with viral hepatitis infection in Cape Coast, Ghana. ( Anabire, NG; Annan, I; Aryee, PA; Eliason, S; Hagan, OCK; Helegbe, GK; Luuse, AT; Obiri-Yaboah, D; Tetteh, WJ, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anabire, NG | 1 |
| Tetteh, WJ | 1 |
| Obiri-Yaboah, D | 1 |
| Annan, I | 1 |
| Luuse, AT | 1 |
| Aryee, PA | 1 |
| Helegbe, GK | 1 |
| Hagan, OCK | 1 |
| Eliason, S | 1 |
| Gao, YJ | 1 |
| Zhang, M | 1 |
| Jin, B | 1 |
| Meng, FP | 1 |
| Ma, XM | 1 |
| Liu, ZW | 1 |
| Su, HB | 1 |
| Zhao, JM | 1 |
| Li, HW | 1 |
| Yang, DH | 1 |
| Liang, WF | 1 |
| Xie, YJ | 1 |
| Zhao, NF | 1 |
| Fan, J | 1 |
| Cakir, N | 1 |
| Pamuk, ON | 1 |
| Umit, H | 1 |
| Midilli, K | 1 |
| Kosozu, K | 1 |
| Seki, S | 1 |
6 other studies available for aspartic acid and Hepatitis B
| Article | Year |
|---|---|
Evaluation of hepatic and kidney dysfunction among newly diagnosed HIV patients with viral hepatitis infection in Cape Coast, Ghana.
Topics: Adult; Alanine Transaminase; Aspartic Acid; Blood Platelets; Coinfection; Cross-Sectional Studies; F | 2019 |
Clinical-pathological analysis of hepatitis B virus recurrence after liver transplantation in Chinese patients.
Topics: Adult; Age Factors; Antiviral Agents; Aspartic Acid; Carcinoma, Hepatocellular; China; DNA, Viral; D | 2014 |
PCR restriction fragment length polymorphism in detection of YMDD variants of viral polymerase in hepatitis B virus patients treated with lamivudine.
Topics: Adolescent; Adult; Amino Acid Motifs; Aspartic Acid; Base Sequence; Child; DNA-Directed DNA Polymera | 2002 |
Successful treatment with adefovir of one patient whose cryoglobulinemic vasculitis relapsed under lamivudine therapy and who was diagnosed to have HBV virologic breakthrough with YMDD mutations.
Topics: Adenine; Amino Acid Motifs; Aspartic Acid; Cryoglobulinemia; Female; Hepatitis B; Hepatitis B virus; | 2006 |
[Clinical study on the effects of L-ornithine-L-aspartate on liver dysfunction].
Topics: Aspartic Acid; Hepatitis; Hepatitis B; Humans; Liver Cirrhosis; Ornithine | 1966 |
[Study of the treatment of liver damage due to several causes in tuberculosis, using ornithine-aspartate].
Topics: Aspartic Acid; Blood Transfusion; Female; Hepatitis; Hepatitis B; Humans; Isoniazid; Male; Ornithine | 1966 |